Patient-centricity has rendered itself the cornerstone of the pharma market since the advent of the technological boom in Industry 4.0. Now, this calls for HCPs and other stakeholders to adopt another tool or strategy to fine-tune consumer expectations. That is nothing but the practice of Patient Journey Mapping (PJM).
Comprehending a patient’s journey delivers a key structure for pharma marketers to draw conclusions and design particular strategies for the patient segment in which their product is focused. It furnishes the whole paradigm from the manifestation of symptoms of a disease to diagnosis, treatment, and post-treatment care. Throughout this pathway, nuanced decisions are made by the patients, insurance providers, caretakers, and HCPs to ensure a smooth treatment process. These decisions are driven by elements such as patient behavior, disease condition, treatment settings, technology, social influence, cost of therapy, etc. All these elements as a whole are responsible for creating a unique patient experience.
Factors Revolving Around Patient Journey Mapping
- Touchpoints-
Now, throughout the patient journey, there happen to be multiple touchpoints. These are crucial fragments of instances during which a patient or prospective patient interacts with the healthcare organization. These discussions might be personal, for instance, a direct interaction between a patient and a caregiver, or non-personal; for example through web apps, advertisements, or websites. These touchpoints make up the gross patient experience.
- Quality Measures-
These are pre-established standards that a healthcare institution sets against which to assess performance when catering to patients’ needs. Analyzing how well individual touchpoints perform against these quality measures helps in the recognition of areas needing improvement. For instance- the average time span of each stage in the patient journey, the cumulative time spent in admission, and any delays in care provisions or diagnosis.
- Customer Satisfaction Levels-
A vital segment of patient journey analytics is consumer satisfaction grades. Assessing data from customer satisfaction surveys at various touchpoints in the patient journey can be beneficial in identifying and rectifying bottlenecks in the healthcare patient experience from the onset of their journey.
Enterprises should dig deeper into the impacts of the pandemic on patient experience, especially the assessment of the patient flow. It would help comprehend how healthcare delivery has changed in a post-pandemic era. This can assist stakeholders in the marketing and sales of medical devices and identify friction points of referral pathways and nuanced stages of care a patient might or might not receive.
The Advantages of Analysing Patient Journeys
As indicated earlier, PJM is a potential tool for comprehending the patient’s needs and preferences. Some of the advantages of patient journey analytics involve:
- Enhancing the patient experience- With the correct analysis of patient journeys, healthcare enterprises and research centers can identify and optimize pain points/gaps in care during the journey to foster a more positive experience. This understanding assists HCPs and manufacturers in customizing their services and products to meet patient needs more effectively.
- Recognizing opportunities- Studying the patient journey can uncover opportunities for new product or service development. It might lead to the design of ground-breaking solutions that address unmet needs or improve existing healthcare practices.
- Boost Patient Engagement- With a stronger comprehension of the patient journey, HCPs and producers can develop targeted solutions to engage patients throughout their journey, even during intermediate follow-up.
For instance, during the COVID pandemic, when patients with mild disease were asked to self-isolate at home, patient journey analytics unraveled that there was a strong need for eHealth services to perpetuate engagement with patients receiving home-based care.
- Supporting Marketing Strategies- PJM leverages pharma enterprises and medical device manufacturers to comprehend the patient decision-making process. This insight can be utilized to develop more focused marketing and educational campaigns.
- Impactful Healthcare Delivery- By gaining holistic knowledge about the patient journey, healthcare institutions can identify areas where healthcare delivery can be optimized to enhance efficiency, for instance- minimizing waiting times and improving patient flow.
Strategizing Your Patient Journey Mapping to Compete in the Market
- Initiate synchronized lab data- gathering accurate information into how severity and disease progression need analysis of lab test results over time. While experts in the life science industry understand the business value of these insights, only a few have been able to unlock them to inform decisions at scale. Implementing a tool that consolidates de-identified data from nuanced lab sources in a single location can harmonize the data and make it compliant in the process. Once streamlined, lab data can be promptly analyzed and linked to other data, offering answers to key clinical queries in no time instead of months.
- Enable prompt multipoint analysis- Holistically visualizing the longitudinal patient journey needs analysis of nuanced patient and provider characteristics, trends, and patterns. For instance, you’ll want to study where, when, and how treatment decisions are made, including the impacts of lab testing and provider touchpoints, as well as what mediums and messaging are most impactful and efficient. The industry needs to incorporate analytics and tools that enable them to promptly-
- Perform physician and patient segmentation targeting (b) determine market size, market opportunity, and patient populations (c) perceive how treatment decisions vary by patient characteristics (d) determine how patients touch-base with nuanced providers (e) calculate how often patients are noticed, treated and tested (f) track medication prevails and compliance (g) comprehend treatment paths and lines of therapy
- Set the stage for prompt iteration- The patient journey assessment doesn’t have to be particular and limited. It can be a perpetual process that enables you to keep tabs on the most updated patient and provider data to track the impact of existing strategies. Healthcare institutions should collaborate with innovative enterprises that equip themselves with new/updated data. And when the time comes, these enterprises should send custom alerts to the healthcare organizations when the new data matches with respective patient profiles in the directory. Since these advanced enterprises are cloud-based, healthcare organizations can perform additional analysis on data sets as often and as their brand strategy demands.
Emerging Trends to Consider by Pharma Companies When Developing a Patient Journey Map
- Result-Driven Care- Payers, as well as the government, have placed greater weightage on patient outcomes, driving pharma enterprises to prove the tangible benefits of their products. In the coming days, technology will certainly be further integrated with prescriptions. Merging meticulous data analytics about nutrition, activity, and the human biological system will offer caregivers and physicians the opportunity to intervene early.
- Patient Demands Engagement- Patients are more involved in evaluating healthcare products and services, all by themselves. It’s high time that brands come up with intriguing opportunities, along with accurate data sharing and trial recruitment.
- Data is accessible around the clock- With the advent of Pharma 4.0, digital technology and online platforms have paved the way for patients to gain access to information previously controlled by pharma companies. These days, patients are seeking other patients’ experiences, methodologies to monitor a drug’s effectiveness, and any tips they can get their hands on to assist them in making the best decision possible for their health and well-being.
Conclusion
Patient flow and PJM both act as cornerstones to drive sales and maximize product uptake in the pharma industry, let alone healthcare as a whole sector. While both of them include the study of the patient’s growth through the treatment pathway, PJM involves the aspects of the patient’s interactions with healthcare systems before and after they receive clinical care.
Therefore, this concludes that pharma enterprises should focus on patient-centricity instead of drugs, which will provide them insights on how pharma decisions are to be made, effectively shaping their patient journey map.
